Cell Impact Q2 2025: Financing secured for operations
While we succeeded in our various customer projects during the second quarter, our sales were weak. The Group’s net sales amounted to SEK 2.1 million (23.8). During the quarter, we carried out a rights issue, which was up to 60 percent guaranteed in advance.The final outcome of the rights issue entailed a capital injection of SEK 39.2 million before issue costs and repayment of the bridge loan. “Since we are waiting for customer orders of larger volumes, this capital injection was necessary to lead and complete our new and ongoing customer projects, bringing them to final product,” said
